(Press-News.org) Despite established connections, study finds almost 60% of U.S. adults are unaware or uncertain of the link between alcohol and cancer
An estimated 75,000 cancer cases are associated with alcohol annually in the U.S.
Researchers suggest implementing new Surgeon General recommendations could be an effective approach to reducing future cancer rates
HOUSTON, MAY 29, 2025 ― Alcohol is a leading preventable cause of cancer, but public awareness of the connection remains strikingly low in the U.S., with just 40% of American adults recognizing alcohol as a cancer risk, according to a new study from The University of Texas MD Anderson Cancer Center.
The findings, published today in JAMA Oncology, reveal that 39% of American adults are not aware of the connection between cancer and alcohol and an additional 20% are uncertain whether they have heard or read about the link. Additionally, of the 5,937 respondents, just over 30% believe that cancer prevention is not possible.
“Despite the well-established association between alcohol and cancer, alcohol consumption has continued to rise in the U.S.,” said corresponding author Sanjay Shete, Ph.D., deputy division head of Cancer Prevention and Population Sciences. “Our findings suggest that many individuals are unaware of the significant benefit in reducing or eliminating alcohol intake. Simply put, the more a person drinks, the greater their risk of developing cancer.”
Consuming alcohol has been linked to at least seven types of cancer, including colorectal, breast, liver, mouth, voice box, throat and esophageal. Each year, alcohol-related cancers claim the lives of more than 20,000 Americans, but nearly 70% of American adults admit to consuming alcoholic beverages. In January 2025, the U.S. Surgeon General issued an advisory about how alcohol increases cancer risk that also called for a new health warning label on alcoholic beverages.
Researchers found that awareness of the link between alcohol and cancer was lowest among Black respondents (30%), those with some college education or less (35.2%), and those who did not believe cancer prevention was possible (31.5%). Alternatively, respondents who had experienced cancer had a higher likelihood of being aware of the connection.
“Given we now know there is an increased risk of cancer, even at low levels of alcohol consumption, it is imperative to improve public awareness,” Shete said. “We hope these findings encourage clinicians to speak with their patients directly and that the immediate revision of drinking guidelines becomes a national priority.”
This study was based on data from the 2022 Health Information National Trends Survey and was measured through the question: “Have you ever heard or read that alcohol increases the risk of cancer?” Possible responses were: “yes,” “no,” or “don’t know.”
Limitations may include the design of the survey, which did not allow researchers to establish a causal relationship between awareness and selected variables.
This study was funded by the National Cancer Institute (P30CA016672) and the Betty B. Marcus Chair in Cancer Prevention. A full list of collaborating authors and their disclosures can be found here.
END
Most Americans unaware of cancer risks associated with drinking alcohol
2025-05-29
ELSE PRESS RELEASES FROM THIS DATE:
New insights into bladder cancer treatment could help improve immunotherapies
2025-05-29
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.
Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) and is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.
BCG is a weakened strain of the bacterium Mycobacterium bovis, which is ...
HIV discovery could open door to long-sought cure
2025-05-29
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly it replicates, and how easily or stubbornly it can reawaken from hiding. These insights bring researchers closer to finding ways to flush out the dormant virus and eliminate it for good.
Thanks to remarkable progress in HIV treatment, the virus can often be suppressed to undetectable levels in the blood, eliminating most disease symptoms, and preventing transmission to others. But HIV never truly ...
The purrfect gene
2025-05-29
Kyoto, Japan -- Whether you are lucky enough to have a cat companion or must merely live this experience vicariously through cat videos, Felis catus is a familiar and comforting presence in our daily lives. Unlike most other feline species, cats exhibit sociality, can live in groups, and communicate both with other cats and humans, which is why they have been humans' trusted accomplices for millennia.
Despite this intimacy, there is still much that we don't know about our feline friends. Numerous behavioral studies have been conducted on other mammal species, but relatively few on cats.
In part to fill this gap, a team of researchers at ...
Researchers find promise in a new peptide drug to combat a deadly brain cancer
2025-05-29
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.
In a study published in May in Cell Death and Disease, researchers identified a previously unknown trait of cancer cells that shows promise for therapeutic intervention. The group outlined the mechanism of action and effectiveness of the experimental drug known as JM2, revealing ...
Two WCM scientists receive inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant
2025-05-29
(New York, May 29, 2025) – Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.
The challenge grant provides $750,000 in funding over three years to support innovative research into ovarian cancer ...
Wyss Institute at Harvard University announces appointment of Natalie Artzi, Ph.D., to Associate Institute Director
2025-05-29
Wyss Institute at Harvard University Announces Appointment of Natalie Artzi, Ph.D.,
to Associate Institute Director
Dr. Artzi will work closely with the Wyss Founding Director Don Ingber and the Wyss executive and senior leadership teams in shaping the strategic direction of the Institute
MAY 29,2025 – (Boston, MA) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D. has been appointed to a newly created position as Associate Institute Director ...
Earlier measles vaccine could help curb global outbreak
2025-05-29
The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states.
The systematic review, led by Murdoch Children’s Research Institute (MCRI), found vaccinating children from as early as four months of age for measles warranted serious discussion given that only 30 per cent of babies in low- and middle-income countries were protected by maternal antibodies by four months of age. Concerningly, this is well below the World Health Organization’s (WHO) recommendation of a first measles dose between 9-12 months old.
The ...
Mixed-valence Cu-based metal-organic framework enables highly efficient CO2 electroreduction to C1 liquid fuels
2025-05-29
Rising atmospheric CO2 levels from fossil fuel dependence have intensified climate threats, driving demand for technologies that convert CO2 into value-added chemicals. Electrocatalytic CO2 reduction (CO2RR) holds promise but faces challenges such as high energy costs, low product selectivity, and competition from hydrogen evolution reactions (HER). A breakthrough by researchers at Tongji University, China, introduces a new catalyst design that overcomes these limitations, paving the way for green chemistry solutions.
The ...
The future of AI regulation: why leashes are better than guardrails
2025-05-29
Herndon, VA, May 29, 2025 – Many policy discussions on AI safety regulation have focused on the need to establish regulatory “guardrails” to protect the public from the risks of AI technology. In a new paper published in the journal Risk Analysis, two experts argue that, instead of imposing guardrails, policymakers should demand “leashes.”
Director of the Penn Program on Regulation and professor at University of Pennsylvania Carey Law School, Cary Coglianese and University of ...
Income inequality undermines support for higher minimum wages
2025-05-29
High levels of income inequality weaken support for raising the minimum wage, which in turn could further worsen income inequality as people believe this is the way things should be, according to research published by the American Psychological Association.
The researchers analyzed data from more than 130,000 protests across the country and conducted eight other experiments that found that an “is-to-ought” reasoning error may be to blame where people view situations as they are and then infer that is the way they should be. That can have ...